Main Conference Sponsor
Sponsors, Stakeholders and Exhibitors
Sponsors
Main Conference Sponsor: Abraxis BioScience Ltd
Abraxis BioScience Ltd
Hatfield Herts AL10 9NA UK
Phone: 01323 723 638 / 07800 708 108
Email: tom.brown@quintiles.com
Contact: Mr Tom Brown
Job Title: Sales Director UK
Exhibition Stand Unit: 25 & 26
Abraxis BioScience Inc. is a fully integrated biotechnology company dedicated to the discovery, development and delivery of next generation therapeutics and core technologies that offer patients innovative and improved treatments for cancer.
The Abraxis BioScience Inc. portfolio includes the world’s first and only protein-bound nanoparticle chemotherapeutic compounds, which are based on its proprietary tumor targeting system known as the nab® technology platform.
From the discovery and research phase to development and commercialisation, Abraxis BioScience Inc. is committed to rapidly enriching the company’s pipeline and accelerating the delivery of breakthrough therapies that will transform the lives of the patients who need them.
Conference Sponsor: Merck Serono
Merck Serono
Bedfont Cross
Stanwell Road
Feltham Middlesex TW14 8NX UK
Phone: 0208 818 7571
Fax: 0208 818 7222
Email: gerry.chamberlain@merckserono.net
Contact: Ms Gerry Chamberlain
Exhibition Stand Unit: 08
Merck Serono is the division for innovative prescription pharmaceuticals of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets innovative small molecules and biopharmaceuticals to help patients with unmet medical needs. In the USA and Canada, EMD Serono operates through separately incorporated affiliates.
With an annual R&D expenditure of around €1bn, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including oncology, neurodegenerative diseases, fertility and endocrinology, as well as new areas potentially arising out of research and development in autoimmune and inflammatory diseases.
For more information, please visit www.merckserono.co.uk
Conference Sponsor: Sanofi Aventsis
Sanofi Aventsis
1 Onslow Street
Guildford
Surrey, GU1 4YS
Phone: 01483 505 515
Fax: 01483 535 432
Email: PeterJohn.Davies@sanofi-aventis.com
Web: www.sanofi-aventis.co.uk
Contact: Peter John Davies
Job Title: Scientific Advisor, Medical Affairs Department
Parallel Session Sponsor: Q Chip Ltd
Q Chip Ltd
Oddfellows House
19 Newport Road
Cardiff CF24 OAA UK
Phone: 029 2048 0180
Fax: 029 2048 4131
Email: nanette.bartram@q-chip.com
Web: www.q-chip.com
Contact: Dr Nanette Bartram
Job Title: Business Development Manager
Q Chip Ltd is a biopharmaceutical drug delivery company developing a range of sustained-release biogeneric and biotherapies products (Q-Sphera™). Q-Sphera are injectable products in a microsphere format which are made by Q Chip’s patented bioencapsulation platform the MicroPlant™ using a very benign process (critical for peptides and complex proteins).
Speaker Sponsor:
British Association For Cancer Research (BACR)
British Association For Cancer Research (BACR)
c/o Leeds Institute for Molecular Medicine
Clinical Sciences Building
St James’s University Hospital
Leeds LS9 7TF
Phone: 0113 206 5611
Fax: 0113 242 9886
Email: j.alexander@leeds.ac.uk
Web: www.bacr.org.uk
Contact: Janet Alexander
Job Title: BACR Administrative Secretary
The BACR is the largest British-based cancer society with a membership of almost 1,200.
It was formed in 1960 to promote the advance of research in relation to all aspects of cancer, both laboratory and clinical, and to encourage the exchange of information.
It achieves this aim by educational and training opportunities for all those involved in the cancer field, particularly the next generation of cancer research professionals
Stakeholder Organisations
Breast Cancer Care Cymru
|
We bring people together, provide information and support, and campaign for improved standards of care. We use our understanding of people's experience of breast cancer and our clinical expertise in everything we do. Our services include Moving forward partnership programmes, information sessions, peer support, young womens forums, living with secondary breast cancer events, Helpline, Ask the Nurse, publications, lingerie evenings and our HeadStrong service for people who are experiencing hair loss due to cancer treatment. All our services are free. |
Cancer Interdisciplinary Research Group |
The Cancer IRG at the School of Medicine is undertaken by an integrated interdisciplinary group of researchers from six departments covering basic, through translational, to clinical research. With a membership of over 50 researchers this group was formed to increase research focus and promote translational research. It covers molecular/cellular biology through to clinical trials and there are collaborative links with researchers in the Schools of Pharmacy and Biosciences undertaking complementary research programmes. The strategy is to continue to take basic research with model systems through to the clinic and, reciprocally, for clinical research to identify additional avenues that need to be studied at a basic level. |
Cancer Research UK
|
Cancer Research UK is the world's leading independent organisation dedicated to cancer research. With a scientific spend of £333 million in 2007/08, we fund over 4,500 world-class scientists, doctors and nurses in England, Scotland, Wales and Northern Ireland. Their combined expertise puts us at the forefront of cancer research. We carry out world-class research to improve our understanding of cancer and find out how to prevent, diagnose and treat different kinds of cancer. We were recently ranked among the top three biomedical research organisations in the world. |
Cancer Research Wales
|
Cancer Research Wales is the only totally independent cancer research charity for Wales founded in 1966 with the philosophy that all money raised will be spent in Wales. Money raised by the charity supports pioneering research projects carried out by internationally renowned scientists and PhD students across the Principality. |
CLIC Sargent
|
CLIC Sargent is the UK.’s leading charity supporting children, teenagers and young adults with cancer. We are here to help as many children and young people as possible survive cancer and make the most of their lives. We help the whole family cope with the trauma of cancer, life after treatment and, in some cases, with bereavement |
Experimental Cancer Medicine Centre |
The aim of the Cardiff ECMC Centre is the identification and validation of biomarkers and the development of novel therapeutic approaches for national trial assessment, specifically in relation to haematology and other cancers. |
Independent Hospices Cymru
|
Independent Hospices Cymru (IHC) is the voice of independent hospices within Wales. Independent hospices can do much to help achieve the wider spread of high quality palliative care. Our members are keen to work in partnership with other providers and the Assembly Government to achieve this aim. |
Macmillan Cancer Support
|
Macmillan Cancer Support improves the lives of people affected by cancer. We provide practical, medical and financial support and push for better cancer care. Cancer affects us all. We can all help. We are Macmillan. For more information call 0808 808 00 00 or go to www.macmillan.org.uk |
Maggies Cancer Caring Centres
|
Maggie's Centres are calm, uplifting drop-in centres where anyone affected by cancer can go whenever they want. Our professionally staffed centres are used by people at the time of diagnosis, throughout treatment and beyond. We offer emotional and psychological support, information, benefits advice and many other forms of support and self-help. Everything we offer is free and non time limited. |
Marie Curie Cancer Care
|
Marie Curie Cancer Care is one of the UK's largest charities. It provides end of life care to people with cancer and other terminal illnesses, allowing them to live out their final days surrounded by the people they love, in their place of choice. Employing more than 2,700 nurses, doctors and other healthcare professionals, it expects to provide care to around 29,000 terminally ill patients in the community and in its hospices this year. |
Tenovus
|
Formed by ten Cardiff businessmen in 1943, Tenovus has grown to become one of Wales’ largest cancer charities bringing research, treatment, emotional support and practical advice right into the heart of the community where people need it most. |
Wales Cancer Bank
|
The Wales Cancer Bank is working with the NHS in Wales to build the first population based cancer tissue resource in the UK. Biomaterials linked to clinical data are available to researchers worldwide for research which could help identify novel profiles for prediction, prognosis and treatment. |
Wales Cancer Institute
|
The members of the Wales Cancer Institute are the basic science community, the Wales Cancer Bank, the Cardiff Experimental Cancer Medicine Centre (ECMC), the Cancer Interdisciplinary Research Group (CIRC), The Wales Cancer Trials Network (WCTN) and the Wales Cancer Trials Unit (WCTU) representing the breadth of cancer research from basic science through to guidelines for the NHS. |
Wales Cancer Trials Network
|
The Wales Cancer Trials Network (WCTN) supports cancer clinical research in Wales. It works to increase involvement and recruitment into prospective trials of cancer treatments and other well designed studies by providing support to researchers which includes funding for research staff and equipment, training, information and co-ordination. |
Wales Cancer Trials Unit
|
The WCTU is a one stop shop for a clinical trial, from the basic idea, to producing reliable evidence to change practice. The WCTU is a National Cancer Research Institute accredited and UKCRC registered Clinical Trials Unit and receives core funding from Cancer Research UK and Marie Curie Cancer Care. |
Exhibitors
ABPI Cymru
|
Exhibition Stand Unit: 18 The ABPI Cymru Wales Industry Group (WIG) was formed as the voice of the pharmaceutical industry in Wales. WIG works in partnership with the National Assembly for Wales, Welsh Assembly Government, NHS Wales, Patient Advocacy Groups and other key stakeholders, to help address the distinctive health needs of the people of Wales. |
CIS Oncology Ltd
|
Exhibition Stand Unit: 22 CIS Oncology is a growing provider of Healthcare IT systems to the NHS and across Europe. ChemoCare, the leading oncology prescribing and management system in the UK is currently implemented in over 60 hospitals and Theriak, our bespoke ePrescribing, administration and bed side verification solution is implemented in over 50 hospitals across Europe. |
Genomic Health Inc.
|
Exhibition Stand Unit: 01 Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX(R) breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. |
Genzyme Therapeutics Ltd
|
Exhibition Stand Unit: 07 One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune disease, and diagnostic testing. |
GlaxoSmithKline UK Oncology
|
Exhibition Stand Unit: 14 GSK Oncology is dedicated to producing innovations in cancer that will make profound differences in the lives of patients. Through GSK’s revolutionary ‘bench to bedside’ approach, we are transforming the way treatments are discovered and developed, resulting in one of the most robust pipelines in the oncology sector. Our worldwide research in oncology includes collaborations with more than 160 cancer centres. GSK is closing in on cancer from all sides with a new generation of patient focused cancer treatments in prevention, supportive care, chemotherapy and targeted therapies. |
IS Pharma
|
Exhibition Stand Unit: 09 IS Pharma plc is a Specialist Hospital Medicines Group, with expertise in both pharmaceuticals and medical devices. The Company is currently focused in the areas of Oncology, Critical Care & Neurology. Find out more about IS Pharma and one of their products, Aloxi®, at stand 9 in the exhibition area. |
Lab21 Healthcare
|
Exhibition Stand Unit: 21 Lab21 leads the way in specialised Oncology diagnostics - particularly personalised cancer management. Our services include KRAS, EGFR, BRAF and BRCA mutation tests, CancerTYPE ID® for classification of primary cancer in CUP, and many others. Rapid turnaround times and dedicated customer support make Lab21 the choice for both public and private sector clinicians. |
Leo Pharma
|
Exhibition Stand Unit: 10 LEO Pharma is among the world’s leading companies in parenteral treatment of thromboembolic disorders and topical dermatology. LEO Pharma is owned entirely by the LEO Foundation and is committed to improving patient care whilst increasing awareness and understanding within its specialist disease areas. With no shareholders, money can be reinvested into what really matters: pioneering treatment for the benefit of patients. For more information about LEO Pharma’s products or educational resources, please telephone 01844 347333 or email: general.uk@leo-pharma.com |
medac UK
|
Exhibition Stand Unit: 12 medac is an innovative German pharmaceutical company with a well-established reputation and experience in oncology, haematology and rheumatology. We are specialists offering a broad spectrum of products from standard cancer chemotherapy to niche speciality medicines. We provide high quality products and seek innovative solutions to your therapeutic problems. |
National Cancer Intelligence Network
|
Exhibition Stand Unit: 16 & 17 The National Cancer Intelligence Network – Using information to improve quality and choice Where possible, NCIN produces UK-based analyses, though several analyses only cover England. |
Novartis Pharmaceuticals Ltd
|
Exhibition Stand Unit: 19 |
Pfizer Worldwide Biopharmaceutical Businesses
|
Exhibition Stand Unit: 20 We are committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Working together, we strive to transform treatment by targeting the right drug for the right patient at the right time. |
Roche Products Ltd
|
Exhibition Stand Unit: 23 & 24 Roche has been a world leader in oncology for over 40 years, discovering, researching and developing innovative treatments for cancer. Now world number one in oncology, the Roche oncology portfolio includes four innovative targeted treatments for breast, colorectal, lung and haematological cancers, along with supportive care treatments for patients undergoing chemotherapy. Roche was the first company to introduce monoclonal antibodies in the treatment of cancer - novel drugs which, unlike chemotherapy target the cancer cells directly. |
Target Ovarian Cancer
|
Exhibition Stand Unit: 02 Target Ovarian Cancer‘s aim is a long and good life for every UK woman diagnosed with ovarian cancer. Find out about the Target Ovarian Cancer Pathfinder Study, pick up copies of our symptoms leaflets (Welsh and English), and see our new resource for women with a recent diagnosis. |
VH Bio Ltd
|
Exhibition Stand Unit: 11 VHBio is a distributor of high quality molecular, immunology and microbiology reagents and instrumentation to the life sciences industry. Our product range includes the AmpliSpeed PCR Cycler for Single Cell PCR analysis and 1µl reactions, Performa DTR Sequencing Clean–Up products, automated DNA extraction platforms, patented acoustic sample mixing devices and SepsiTest for the rapid detection of Sepsis. |
